EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL/6 mice

Pericles Fabrício Gomes-Filho, Carolina da Silva Valentim, Cherley Borba Vieira Andrade, Verônica Aiceles de Medeiros Pinto, Raíssa Leal de Carvalho Dos Santos Cunha, Paulo Rogerio Silva de Paiva-Júnior, Rebecca Roosevelt da Conceição Souza Guedes, João Lucas do Céu Amparo, Isalira Peroba Ramos, Luciana Lontro Alves, Aluana Santana Carlos, Jéssica Gomes Pereira und 6 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05723-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Pericles Fabrício Gomes-Filho und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Ultrastructure and Tissue Biology, Department of Histology and Embryology, State University of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Fasting, Fatty Liver. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Do Estado Do Rio De Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic steatotic liver disease (MASLD) lacks effective pharmacological therapies targeting mitochondrial dysfunction, a central driver of disease progression. We hypothesized that dapagliflozin attenuates MASLD progression by promoting an indirect systemic fasting-mimicking state, thereby proposing the hypothesis of mitochondrial restoring mitochondrial bioenergetics restoration via modulation of the SIRT1–PGC-1α signaling pathway. C57BL/6 mice were fed either a control diet or a high-fat diet, associated, respectively, with drinking water or water with 15% fructose. From the 10th to the 16th week, the animals received, by orogastric gavage, saline solution or dapagliflozin (10 mg/kg). Biochemical analyses, magnetic resonance imaging, oral glucose tolerance tests, stereology, and ultrastructural analysis of the liver, as well as Western blotting using mitochondrial markers, were performed. The study showed that exposure to the high-fat diet associated with fructose effectively mimicked the main aspects of obesity and MASLD. Intervention resulted in a reduction in adiposity without compromising muscle mass, preservation of mitochondrial integrity, improvement in mitochondrial bioenergetics, and attenuation of steatosis and hepatic cellular stress. These results suggest an association with the NT-PGC-1α–NRF1 axis; our study hypothesizes that this acts as a compensatory mechanism. These findings support further investigation of dapagliflozin as a potential therapeutic strategy for MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsGlucosidesFastingFatty LiverSodium-Glucose Transporter 2 InhibitorsAnimalsMice, Inbred C57BLDiet, High-FatMalePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaFructoseLiverSirtuin 1MiceEnergy Metabolism

Stichwörter der Autor:innen

High-fat dietHigh-fructoseInhibitors SGLT2MASLDNT-PGC-1aTransmission electron microscopy

Substanzen

Benzhydryl CompoundsdapagliflozinGlucosidesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseFructoseSirtuin 1Sirt1 protein, mouseSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Laboratory of Ultrastructure and Tissue Biology, Department of Histology and Embryology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • National Center for Structural Biology and Bioimaging, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Pre-Clinical Research Laboratory, Iguaçu University, Nova Iguaçu, Rio de Janeiro, Brazil.
  • Laboratory of Endocrine Physiology, Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Laboratory of Radiological Sciences, Department of Radiological Sciences, State University of Rio de Janeiro, Rio de Janeir, Brazil.
  • Laboratory of Interdisciplinary Medical Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Förderung

  • Universidade Do Estado Do Rio De Janeiro

Zitieren

APA

Gomes-Filho, P. F., Valentim, C. D. S., Andrade, C. B. V., Pinto, V. A. M., Cunha, R. L. C. D. S., de Paiva-Júnior, P. R. S., Guedes, R. R. D. C. S., Amparo, J. L. D. C., Ramos, I. P., Alves, L. L., Carlos, A. S., Pereira, J. G., Nehme, N. M., Lisboa, P. C., Ferreira-Machado, S. C., Rabelo, K., de Carvalho, J. J., & da Silva, J. F. R. (2026). Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL/6 mice. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05723-w

Vancouver

Gomes-Filho PF, Valentim CDS, Andrade CBV, Pinto VAM, Cunha RLCDS, de Paiva-Júnior PRS, et al. Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL/6 mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05723-w

BibTeX
@article{GomesFilho2026,
  author = {Gomes-Filho, Pericles Fabrício and Valentim, Carolina da Silva and Andrade, Cherley Borba Vieira and Pinto, Verônica Aiceles de Medeiros and Cunha, Raíssa Leal de Carvalho Dos Santos and de Paiva-Júnior, Paulo Rogerio Silva and Guedes, Rebecca Roosevelt da Conceição Souza and Amparo, João Lucas do Céu and Ramos, Isalira Peroba and Alves, Luciana Lontro and Carlos, Aluana Santana and Pereira, Jéssica Gomes and Nehme, Nathália Medeiros and Lisboa, Patrícia Cristina and Ferreira-Machado, Samara Cristina and Rabelo, Kíssila and de Carvalho, Jorge José and da Silva, Jemima Fuentes Ribeiro},
  title = {Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL/6 mice},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05723-w}
}
Kostenlos starten →